Hao Cheng

3PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 01, 2025
Tislelizumab and Hypofractionated Radiotherapy plus Nab-Paclitaxel/Gemcitabine as Conversion Therapy for BRPC/LAPC: A Phase II Trial with Dynamic Biomarker Monitoring.

Jiayao Ni, Yi Sun, Hao Cheng

|Aug 04, 2025
Survival and pathological response in pancreatic ductal adenocarcinoma after preoperative therapy with PD-1 blockade plus chemoradiotherapy followed by surgical resection.

Elyar Abaydulla, Qi Li, Jialing Li

|Jul 25, 2020
Ligand-targeted polymerase chain reaction for the detection of folate receptor-positive circulating tumour cells as a potential diagnostic biomarker for pancreatic cancer.

Hao Cheng, Wei He, Jun Yang

Pageof 1

Frequent Collaborators

1 joint publications

Jiayao Ni

1 joint publications

Yi Sun

1 joint publications

Xinyuan Bai

1 joint publications

Fan Tong